Appia Bio is a biotechnology startup dedicated to the discovery and development of allogeneic cell therapies with a scalability that increases access for cancer patients.
Market:Cell therapy has brought dramatic improvements in efficacy and durable remission rates in certain hematological cancers, but it has reached a limited number of patients. Appia's novel, proprietary platform can programmably generate a broad array of NKT and T cell types from hematopoietic stem cells. Through breakthrough engineering technologies, Appia Bio aims to make cell therapy readily available for patients by generating allogeneic and off-the-shelf products.
Location: Culver City, CA
Back to Top